NCT04028063 2026-01-27Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue SarcomasUniversity of Colorado, DenverPhase 2 Recruiting65 enrolled
NCT05864534 2025-10-03Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern UniversityPhase 2 Recruiting25 enrolled
NCT04607200 2022-01-11AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable AngiosarcomaAgenus Inc.Phase 2 Withdrawn